Dr. Touma’s research interests include outcome measurement, particularly for systemic lupus erythematosus including assessment of lupus disease activity and quality of life. He is the principal investigator on a project determining the best instruments for the screening and the diagnosis of cognitive dysfunction in patients with lupus. In addition, this project will identify the role of blood biomarkers in the assessment and management of patients with cognitive dysfunction. Dr. Touma is also involved in collaborative projects with the scientists at the Institute for Work and Health related to the review of critical appraisal tools of studies on measurement properties.
Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.
PLoS One. 2018;13(5):e0196117
Rheumatology (Oxford). 2018 Apr 20;:
Clin Exp Rheumatol. 2018 Apr 13;
Rheum Dis Clin North Am. 2018 May;44(2):177-188
What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis.
Semin Arthritis Rheum. 2018 Feb 21;:
Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments.
Lupus Sci Med. 2017;4(1):e000239
Biomed Res Int. 2017;2017:5312960
Semin Arthritis Rheum. 2017 Aug 03;:
J Rheumatol. 2017 Sep 01;:
Comparison of Spot Urine Protein to Creatinine Ratio to 24-Hour Proteinuria to Identify Important Change Over Time in Proteinuria in Lupus.
J Clin Rheumatol. 2017 Sep;23(6):301-307
Clinician Investigator, Krembil Research Institute (Krembil)
Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
Assistant Professor, Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Toronto